These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22788748)
1. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice. Bishop LR; Helman D; Kovacs JA BMC Immunol; 2012 Jul; 13():39. PubMed ID: 22788748 [TBL] [Abstract][Full Text] [Related]
2. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii. Tesini BL; Wright TW; Malone JE; Haidaris CG; Harber M; Sant AJ; Nayak JL; Gigliotti F Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28031260 [No Abstract] [Full Text] [Related]
3. Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. Theus SA; Andrews RP; Linke MJ; Walzer PD J Eukaryot Microbiol; 1997; 44(2):96-100. PubMed ID: 9109259 [TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant Pneumocystis carinii p55 antigen provides partial protection against infection: characterization of epitope recognition associated with immunization. Smulian AG; Sullivan DW; Theus SA Microbes Infect; 2000 Feb; 2(2):127-36. PubMed ID: 10742685 [TBL] [Abstract][Full Text] [Related]
5. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection. Walzer PD; Djawe K; Levin L; Daly KR; Koch J; Kingsley L; Witt M; Golub ET; Bream JH; Taiwo B; Morris A J Infect Dis; 2009 May; 199(9):1335-44. PubMed ID: 19301979 [TBL] [Abstract][Full Text] [Related]
7. Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii. Theus SA; Linke MJ; Andrews RP; Walzer PD Infect Immun; 1993 Nov; 61(11):4703-9. PubMed ID: 8406869 [TBL] [Abstract][Full Text] [Related]
8. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Mei Q; Turner RE; Sorial V; Klivington D; Angus CW; Kovacs JA Infect Immun; 1998 Sep; 66(9):4268-73. PubMed ID: 9712777 [TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. Theus SA; Andrews RP; Steele P; Walzer PD J Clin Invest; 1995 Jun; 95(6):2587-93. PubMed ID: 7769101 [TBL] [Abstract][Full Text] [Related]
10. Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms. Blount RJ; Jarlsberg LG; Daly KR; Worodria W; Davis JL; Cattamanchi A; Djawe K; Andama A; Koch J; Walzer PD; Huang L; PLoS One; 2012; 7(12):e51545. PubMed ID: 23284710 [TBL] [Abstract][Full Text] [Related]
11. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection. Ruan S; Cai Y; Ramsay AJ; Welsh DA; Norris K; Shellito JE Vaccine; 2017 Jan; 35(4):672-679. PubMed ID: 28012778 [TBL] [Abstract][Full Text] [Related]
12. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia. Gingo MR; Lucht L; Daly KR; Djawe K; Palella FJ; Abraham AG; Bream JH; Witt MD; Kingsley LA; Norris KA; Walzer PD; Morris A J Acquir Immune Defic Syndr; 2011 Jul; 57(3):190-6. PubMed ID: 21372726 [TBL] [Abstract][Full Text] [Related]
14. Characterization of p57, a Stage-Specific Antigen of Pneumocystis murina. Bishop LR; Davis AS; Bradshaw K; Gamez M; Cisse OH; Wang H; Ma L; Kovacs JA J Infect Dis; 2018 Jun; 218(2):282-290. PubMed ID: 29471356 [TBL] [Abstract][Full Text] [Related]
15. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens. Daly K; Koch J; Respaldiza N; de la Horra C; Montes-Cano MA; Medrano FJ; Varela JM; Calderon EJ; Walzer PD Clin Microbiol Infect; 2009 Oct; 15(10):937-42. PubMed ID: 19416292 [TBL] [Abstract][Full Text] [Related]
17. Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients. Blount RJ; Daly KR; Fong S; Chang E; Grieco K; Greene M; Stone S; Balmes J; Miller RF; Walzer PD; Huang L PLoS One; 2017; 12(7):e0180212. PubMed ID: 28692651 [TBL] [Abstract][Full Text] [Related]
18. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. Gigliotti F; Garvy BA; Haidaris CG; Harmsen AG J Infect Dis; 1998 Jul; 178(1):235-42. PubMed ID: 9652446 [TBL] [Abstract][Full Text] [Related]
19. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Gigliotti F; McCool T Parasitol Res; 1996; 82(1):90-1. PubMed ID: 8825453 [TBL] [Abstract][Full Text] [Related]
20. Western blot analysis of rat Pneumocystis carinii antigens using convalescent rat sera and rabbit anti-gp120. Pascale JM; Shaw MM; Bartlett MS; Smith JW; McLaughlin GL J Eukaryot Microbiol; 1996; 43(5):30S. PubMed ID: 8822834 [No Abstract] [Full Text] [Related] [Next] [New Search]